[{"address1": "180 North LaSalle Street", "address2": "Suite 1600", "city": "Chicago", "state": "IL", "zip": "60601", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase I clinical trial for the treatment of hypothyroidism; and non-aqueous XeriSol and XeriJect technologies for various therapies. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 377, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 918153, "exercisedValue": 0, "unexercisedValue": 148377}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 681142, "exercisedValue": 0, "unexercisedValue": 15586}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 695443, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 1206766, "exercisedValue": 0, "unexercisedValue": 590310}, {"maxAge": 1, "name": "Dr. Kenneth E. Johnson Pharm. D., Pharm.D.", "age": 61, "title": "Senior VP of Global Development & Medical Affairs", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 596967, "exercisedValue": 0, "unexercisedValue": 31173}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.97, "open": 4.01, "dayLow": 3.69, "dayHigh": 4.0103, "regularMarketPreviousClose": 3.97, "regularMarketOpen": 4.01, "regularMarketDayLow": 3.69, "regularMarketDayHigh": 4.0103, "payoutRatio": 0.0, "beta": 1.226, "forwardPE": -16.795454, "volume": 1887446, "regularMarketVolume": 1887446, "averageVolume": 1624667, "averageVolume10days": 1975050, "averageDailyVolume10Day": 1975050, "bid": 3.64, "ask": 3.75, "bidSize": 1, "askSize": 1, "marketCap": 550854272, "fiftyTwoWeekLow": 1.69, "fiftyTwoWeekHigh": 4.1, "priceToSalesTrailing12Months": 2.9400692, "fiftyDayAverage": 3.4914, "twoHundredDayAverage": 2.8401, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 793416384, "profitMargins": -0.33685002, "floatShares": 141752616, "sharesOutstanding": 149080992, "sharesShort": 10485254, "sharesShortPriorMonth": 10188099, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.070300005, "heldPercentInsiders": 0.03929, "heldPercentInstitutions": 0.44926998, "shortRatio": 7.03, "shortPercentOfFloat": 0.0721, "impliedSharesOutstanding": 149080992, "bookValue": -0.19, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -63113000, "trailingEps": -0.43, "forwardEps": -0.22, "enterpriseToRevenue": 4.235, "enterpriseToEbitda": -23.997, "52WeekChange": 0.31893682, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 3.695, "targetHighPrice": 6.6, "targetLowPrice": 3.0, "targetMeanPrice": 5.1, "targetMedianPrice": 5.0, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 69402000, "totalCashPerShare": 0.466, "ebitda": -33063000, "totalDebt": 270964992, "quickRatio": 1.215, "currentRatio": 1.789, "totalRevenue": 187360992, "revenuePerShare": 1.301, "returnOnAssets": -0.08701, "grossProfits": 152436992, "freeCashflow": -30717750, "operatingCashflow": -31485000, "revenueGrowth": 0.123, "grossMargins": 0.8136, "ebitdaMargins": -0.17647, "operatingMargins": -0.23758, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Xeris Biopharma Holdings, Inc.", "longName": "Xeris Biopharma Holdings, Inc.", "exchange": "NMS", "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -6.9269543, "regularMarketPrice": 3.695, "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1740169688, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "regularMarketChange": -0.2750001, "regularMarketDayRange": "3.69 - 4.0103", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1624667, "fiftyTwoWeekLowChange": 2.0049999, "fiftyTwoWeekLowChangePercent": 1.1863904, "fiftyTwoWeekRange": "1.69 - 4.1", "fiftyTwoWeekHighChange": -0.40499997, "fiftyTwoWeekHighChangePercent": -0.09878048, "fiftyTwoWeekChangePercent": 31.893682, "earningsTimestampStart": 1741089600, "earningsTimestampEnd": 1741435200, "earningsCallTimestampStart": 1731072600, "earningsCallTimestampEnd": 1731072600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.43, "epsForward": -0.22, "epsCurrentYear": -0.245, "priceEpsCurrentYear": -15.081632, "fiftyDayAverageChange": 0.20359993, "fiftyDayAverageChangePercent": 0.058314696, "twoHundredDayAverageChange": 0.8548999, "twoHundredDayAverageChangePercent": 0.3010105, "priceToBook": -19.447369, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Xeris Pharmaceuticals, Inc.", "nameChangeDate": "2025-02-21", "cryptoTradeable": false, "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]